MedTrace Logo

Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause

NCT04757922 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-01-26

No results posted yet for this study

Summary

The aim of this study is to evaluate the long-term safety of on the onset of menopause.

Conditions

Interventions

PROCEDURE

Opportunistic salpingectomy / bilateral salpingectomy

An opportunistic salpingectomy refers to removal of the salpinges without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases. Therefore, a so-called opportunistic salpingectomy is a method of female sterilization.

Sponsors & Collaborators

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jurgen MJ Piek, MD, PhD · Catharina Ziekenhuis

  • Joanne A de Hullu, MD, PhD · University Medical Center Nijmegen

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2035-01-01
Completion
2036-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04757922 on ClinicalTrials.gov